These include an alteration of tumor cell metabolism so that, for instance, indoleamine-2,3-dioxygenase (IDO)-expressing myeloid suppressor cells degrade more tryptophan and produce the immunosuppressive metabolites (e.g., kynurenine), which in turn shuts down T cell expansion [98]. This evidence concerns the gene IDO1 and neoplasm.